DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 121 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2015. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,047,250 | +58.8% | 1,425,000 | +38.9% | 0.38% | +68.8% |
Q2 2023 | $13,257,031 | +405.4% | 1,026,086 | +310.4% | 0.22% | +40.0% |
Q3 2016 | $2,623,000 | -28.0% | 250,000 | 0.0% | 0.16% | -28.3% |
Q2 2016 | $3,645,000 | -24.2% | 250,000 | 0.0% | 0.22% | -17.1% |
Q1 2016 | $4,810,000 | -20.4% | 250,000 | 0.0% | 0.27% | -10.9% |
Q4 2015 | $6,040,000 | -12.3% | 250,000 | -10.9% | 0.30% | -24.5% |
Q3 2015 | $6,888,000 | +51.2% | 280,700 | +44.3% | 0.40% | +61.9% |
Q2 2015 | $4,556,000 | +59.4% | 194,500 | +52.7% | 0.25% | +14.9% |
Q1 2015 | $2,858,000 | – | 127,400 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |